Home / Health / Mandy Moore: My Kids Fought RSV, Now My Baby is Protected
Mandy Moore: My Kids Fought RSV, Now My Baby is Protected
18 Feb
Summary
- Mandy Moore experienced overwhelming fear when her sons contracted RSV.
- RSV is the leading cause of hospitalization in infants.
- Beyfortus offers protection against serious RSV lung infection for babies.
Mandy Moore recently spoke about the profound impact RSV had on her family, detailing an overwhelming period in 2023 when both of her sons were simultaneously ill with the virus. This experience left the actress and singer/songwriter feeling deeply helpless, a sentiment that significantly influenced her approach to protecting her youngest child, daughter Lou.
Moore highlighted that RSV poses a considerable risk to infants, being the primary cause of hospitalizations, with a significant percentage of affected babies having no pre-existing health conditions. As RSV season typically spans from fall through spring, she sought to proactively protect Lou, who was born in September. Her pediatrician emphasized the importance of RSV protection year-round.
This led Moore and her husband to discover Beyfortus (nirsevimab-alip), a non-vaccine monoclonal antibody treatment. This preventative option provides protection against severe RSV lung infections during a baby's initial RSV season, lasting for about five months. Moore expressed immense relief that Lou would be safeguarded during her first RSV season, especially after witnessing her sons' ordeal.
